New diabetes clinical trial: MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity

Published on: 2026-04-01T04:00:00Z
Conditions: Prediabetes; Insulin Resistance; Overweight/Obesity
Interventions: Drug: MOTS-c (MDP); Drug: Placebo; Other: Route Subcutaneous injection; Other: Regimen
Sponsors: Hudson Biotech
Recruiting
https://ift.tt/qpDQfR3

Comments